Sandimmune
RxNorm concept 202816, brand name (bn).
- RxCUI
- 202816
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/202816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- cyclosporine Oral Solution [Sandimmune] (SBDF, ingredient of)
- cyclosporine 100 MG Oral Capsule [Sandimmune] (SBD, ingredient of)
- cyclosporine 25 MG Oral Capsule [Sandimmune] (SBD, ingredient of)
- 5 ML cyclosporine 50 MG/ML Injection [Sandimmune] (SBD, ingredient of)
- cyclosporine 100 MG/ML Oral Solution [Sandimmune] (SBD, ingredient of)
- cyclosporine Oral Capsule [Sandimmune] (SBDF, ingredient of)
- cyclosporine 100 MG/ML [Sandimmune] (SBDC, ingredient of)
- cyclosporine 100 MG [Sandimmune] (SBDC, ingredient of)
- cyclosporine 25 MG [Sandimmune] (SBDC, ingredient of)
- cyclosporine 50 MG/ML [Sandimmune] (SBDC, ingredient of)
- Sandimmune Injectable Product (SBDG, ingredient of)
- Sandimmune Oral Liquid Product (SBDG, ingredient of)
- Sandimmune Oral Product (SBDG, ingredient of)
- Sandimmune Pill (SBDG, ingredient of)
- cyclosporine Injection [Sandimmune] (SBDF, ingredient of)
- cyclosporine (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 202816 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/202816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 202816. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.